Table 2 Pancreaticoduodenectomy for pancreatic cancer after esophagectomy for esophageal cancer
Year | Authors | Age | Gender | Interval of operation (year) | Preserved vessels | Adjuvant chemotherapy or radiation | Prognosis |
|---|---|---|---|---|---|---|---|
2011 | Fraguilidis | 50 | Male | 13 | RGEA | Not described | 1Â year and 2Â months, liver metastasis, alive |
2014 | Inoue | 72 | Male | 10 | RGEA, RGEV | Not described | 6 months, no recurrence, alive |
2014 | Nandy | 70 | Male | 3 | Not described | Capetibabine, gemcitabine, radiation | Dead, peritoneal dissemination, liver metastasis, < 1 year |
2015 | Okochi | 70 | Male | 5 | RGEA | Not described | 8 months, alive |
2019 | Orii | 79 | Male | 11 | RGEA, RGEV, RGA, RGV | Not described | 5Â years and 2Â months, no recurrence, alive |
|  | Our case | 78 | Male | 7 | RGEA, RGEV, RGA | S-1 | 5 months, no recurrence, alive |